Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2025 Earnings Call Transcript May 8, 2025
John Menditto – VP of IR and Corporate Communications:
David Mazzo – President and CEO:
James Nisco – SVP of Finance and Treasury and Chief Accounting Officer:
Kristen Buck – EVP of R&D and Chief Medical Officer:
Operator: Welcome to the Lisata Therapeutics First Quarter 2025 Financial Results and Business Update Conference Call. Currently, all participants are in listen-only mode. Following management’s...
